Radiation Dose Management Market

The global radiation dose management market in terms of revenue was estimated to be worth $343 million in 2023 and is poised to reach $654 million by 2028, growing at a CAGR of 13.8% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Growth of the market is mainly driven by risng incidence of chronic diseases, the increasing installation of medical imaging modalities, and govenrment mandates pertaining to the concerns over radiation dose exposure.

Global Radiation Dose Management Market Trend

To know about the assumptions considered for the study, Request for Free Sample Report

Global Radiation Dose Management Market Dynamics

DRIVER: Growing concerns over radiation exposure

In the last two decades, radiation exposure to patients has increased significantly. The increasing utilization of medical imaging procedures, such as X-rays, CT scans, and nuclear medicine, across a diverse range of medical specialties, is contributing to higher radiation exposure concerns. The need for precise diagnosis and treatment planning has also led to a rise in the number of imaging procedures, amplifying concerns regarding radiation-induced side effects, including the risk of cancer. As a result, regulatory bodies and healthcare organizations are imposing strict guidelines and regulations to limit radiation doses and ensure patient safety.

Moreover, integration of artificial intelligence (AI) and machine learning (ML) into radiation dose management systems is enhancing the efficiency by analysing vast datasets and optimizing radiation exposure based on individual patient characteristics. This has addressed concerns related to radiation overexposure in the field of radiation dose management.

OPPORTUNITY: Growing focus on oncology and nuclear medicine

Across the globe, an increasing number of oncology and nuclear medicine procedures are being performed owing to their high imaging efficiency.  According to WHO, cancer is leading cause of death. Annually, 19.3 million new cancer cases are expected to be reported worldwide by 2025. Thus, the rising incidence and prevalence of cancer is a key factor supporting the market growth. Moreover, interventional radiology and nuclear medicine are also playing increasingly vital roles in both diagnostic and therapeutic procedures. These modalities are offering minimally invasive alternatives to traditional surgical interventions, providing higher precision and reduced patient recovery times. Healthcare providers and regulatory bodies are also recognizing the importance of implementing comprehensive strategies to monitor, track, and optimize radiation doses in these dynamic and evolving medical fields.

In order to meet the needs of end users, several industry players, including Philips and Bayer Healthcare, are offering dose management software, particularly for RDM in nuclear medicine and interventional imaging. Although CT applications account for a large share of the radiation dose management market, the interventional radiology and nuclear medicine applications are expected to offer significant growth opportunities in the next five years.

CHALLENGE: Lack of benchmarking for dose optimization across the globe

The efficient use of radiation dose management software to achieve dose reduction is hampered by the lack of government-defined standards and standardised processes for radiation dose benchmarking across all radiology procedures. There is absence of standardized protocols for all examination types, imaging modalities, and patients of all sizes and age groups, at a global level.  Thus, the lack of global benchmarking standards poses a significant obstacle to the growth and effectiveness of radiation dose management solutions, impacting their ability to address the increasing exposure of patients to radiation during medical imaging procedures.

Radiation Dose Management Market Ecosystem

The radiation dose management market ecosystem comprises entities responsible for delivering these solutions to end users. The demand continues to grow and expand as hospitals, ambulatory surgery centres, diagnostic and imaging centres implement these solutions to optimize dose management, improve dose tracking and focus on patient-centric care. Solution and service providers continue to enhance and mature their offerings to increase value addition.

The services offered includes support & maintenance services, implementation & integration services, consulting services, and education & training services.

The integrated solution segment of the radiation dose management industry is expected to grow at the highest CAGR from 2023 to 2028

Based on product & service, the radiation dose management market is segmented into radiation dose management solutions and radiation dose management services. The radiation dose management solutions segment is further bifurcated into standalone solutions and integrated solutions. The integrated solution is projected to witness the highest growth from 2023 to 2028. The increasing demand for cost-effective and easily accessible healthcare services, streamlined workflow management, and enhanced quality care is the major factor supporting the growth of this segment.

The computed tomography segment accounted for the largest share of the radiation dose management industry in 2022

By modality, the radiation dose management market is segmented into computed tomography, fluoroscopy & interventional imaging, radiography, mammography, and nuclear medicine. The computed tomography segment accounted for the largest market share in 2022. The large share of this segment can be attributed to increasing prevalence of targeted diseases, such as cancer and cardiovascular diseases, for diagnosis and monitoring. Moreover, strict regulations for patient safety and compliance with legislative and accreditation requirements have forced healthcare providers to adopt CT scans and radiation dose management solutions.

Hospitals accounted for the largest share of the radiation dose management industry in 2022

Based on end-users, the radiation dose management market is segmented into hospitals and healthcare system, ambulatory surgery centres, diagnostic and imaging centres and other end users. The hospital segment accounted for the largest share of the radiation dose management market in 2022. The growth of this segment is primarily attributed to the growing acceptance of telehealth, teleconsultation, within the healthcare professional community, aiming to alleviate the strain on healthcare facilities. Additionally, the convenience provided by radiation dose management solutions enables healthcare providers to access patient dose records swiftly, facilitate real-time dose exposure, enhance data management thereby fostering an increased adoption of these services among healthcare providers.

To know about the assumptions considered for the study, download the pdf brochure

North America accounted for the largest share of the radiation dose management industry in 2022

Based on the region, the radiation dose management market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America accounted for the largest share of the radiation dose management market. The region's robust growth is attributed to substantial healthcare IT expenditures, coupled with a high penetration of innovative radiation software solutions. The region's favourable conditions, including the presence of key industry players and the emergence of startups, are poised to further drive the adoption of radiation dose management solution market.

Prominent players in radiation dose management market include Bayer AG (Germany), GE Healthcare (US), Philips Healthcare (Netherlands), Siemens Healthcare (Germany), FUJIFILM Holdings Corporation (Japan), Canon Inc. (Japan), PACSHealth, LLC (US), Sectra AB (Sweden), Bracco Imaging S.P.A. (Italy), Qaelum N.V. (Belgium), Agfa Healthcare (Belgium), Novarad Corporation (US), Medic Vision (US), Guerbet (France), Medsquare (France), INFINITT Healthcare Co. Ltd. (South Korea), Volpara Helath Limited. (New Zealand), Medic Vision (Israel), Imalogix (US)., Dedalus S.P.A (Italy) , Nanjing Perlove Medical Equipment CO., LTD. (China), Mirion Technologies, Inc. (US),  Landauer (US), Polimaster (Austria) , and Fortive (US).

Scope of the Radiation Dose Management Industry

The study categorizes the Radiation Dose Management Market to forecast revenue and analyze trends in each of the following submarkets:

By Product & Services

• Radiation Dose Management Solutions
  • Standalone Solutions
  • Integrated Solutions
• Radiation Dose Management Services
  • Support & Maintenance Services
  • Implementation & Integration Services
  • Consulting Services
  • Education & Training Services
  • Radiation Dose Management

By Modality

• Computed Tomography
• Fluoroscopy & Interventional Imaging
• Radiography
• Mammography
• Nuclear Medicine

By Mode of Deployment

• On-Premises
• Cloud-Based
• Web-Based

By Revenue Model

• Capital/Annual Purchase Model
• Pay-Per Procedure Model

By Application

• Oncology
• Cardiology
• Dental
• Orthopaedic Application
• Other Application (Neuroimaging, Genitourinary Imaging, etc)

By End-User

• Hospitals and Healthcare System
• Ambulatory Surgery Centers
• Diagnostic and Imaging Centers
• Other End-users (Academic Research Institutes, Public and Private Research Laboratories)

By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • RoE
• Asia Pacific
  • Japan
  • China
  • India
  • RoAPAC
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC Countries
  • Rest of Middle East and Africa

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst